Associations of Objectively Assessed Physical Activity and Sedentary Time With Health-Related Quality of Life Among Colon Cancer Survivors

被引:73
作者
Vallance, Jeff K. [1 ]
Boyle, Terry [2 ]
Courneya, Kerry S. [3 ]
Lynch, Brigid M. [4 ,5 ]
机构
[1] Athabasca Univ, Fac Hlth Disciplines, Athabasca, AB T9S 3A3, Canada
[2] Univ Western Australia, Western Australia Inst Med Res, Epidemiol Grp, Perth, WA 6009, Australia
[3] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada
[4] Baker IDI Heart & Diabet Inst, Phys Act Lab, Melbourne, Vic, Australia
[5] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
physical activity; sedentary time; health-related quality of life; accelerometer; FUNCTIONAL ASSESSMENT; FATIGUE; BEHAVIOR; ANCHOR; ANEMIA; SCALE;
D O I
10.1002/cncr.28779
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The primary purpose of this study was to determine associations of accelerometer-assessed moderate-to vigorous-intensity physical activity (MVPA) and sedentary time with health-related quality of life (HRQoL) and physical function and well-being in colon cancer survivors. METHODS: Colon cancer survivors (N=178) from Alberta, Canada (n=92) and Western Australia (n=86) completed a mailed survey that assessed HRQoL (Functional Assessment of Cancer Therapy-Colorectal), physical function and wellbeing (Trial Outcome Index-Colorectal), and relevant covariates. MVPA and sedentary time were assessed using the Actigraph GT3X+ accelerometer (60-second epochs) via a 7-day monitoring protocol. Average daily MVPA and sedentary time was corrected for wear time and then examined as quartiles. RESULTS: Adjusting for relevant demographic, behavioral, and clinical covariates, a significant difference in HRQoL scores emerged between quartile 1 (Q1) and Q4 (M-diff=11.5, P=.038). For physical function and wellbeing, a significant difference emerged between Q1 and Q4 (M-diff=9.1, P=.009). For fatigue, a significant difference emerged between Q1 and Q4 (M-diff=7.1, P=.05). Significant differences were also observed for between Q1 and Q3 (M-diff=2.4, P=.041), and Q1 and Q4 (M-diff=3.5, P=.002) for colorectal cancer-specific symptoms. There were no statistically significant associations of sedentary time with HRQoL, physical function and well-being, fatigue, or colorectal cancer-specific symptoms. CONCLUSIONS: Objectively measured MVPA, but not sedentary time, was associated with better HRQoL, physical function and well-being, and colorectal cancer-specific symptoms in colon cancer survivors. For MVPA, differences met or exceeded contemporary cutpoints for determining clinically important differences. (C) 2014 American Cancer Society.
引用
收藏
页码:2919 / 2926
页数:8
相关论文
共 26 条
[1]   Recommendations to Improve the Accuracy of Estimates of Physical Activity Derived From Self Report [J].
Ainsworth, Barbara E. ;
Caspersen, Carl J. ;
Matthews, Charles E. ;
Masse, Louise C. ;
Baranowski, Tom ;
Zhu, Weimo .
JOURNAL OF PHYSICAL ACTIVITY & HEALTH, 2012, 9 :S76-S84
[2]  
[Anonymous], 2008, 2008 PHYS ACT GUID A
[3]  
Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/h2012-024, 10.1139/H2012-024]
[4]   Self-Reported Physical Activity: Its Correlates and Relationship with Health-Related Quality of Life in a Large Cohort of Colorectal Cancer Survivors [J].
Buffart, Laurien M. ;
Thong, Melissa S. Y. ;
Schep, Goof ;
Chinapaw, Mai J. M. ;
Brug, Johannes ;
van de Poll-Franse, Lonneke V. .
PLOS ONE, 2012, 7 (05)
[5]  
Cella D, 1997, SEMIN HEMATOL, V34, P13
[6]   Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales [J].
Cella, D ;
Eton, DT ;
Lai, JS ;
Peterman, AH ;
Merkel, DE .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 24 (06) :547-561
[7]   Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening [J].
Cella, D ;
Hahn, EA ;
Dineen, K .
QUALITY OF LIFE RESEARCH, 2002, 11 (03) :207-221
[8]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[9]  
Courneya K S, 1997, J Altern Complement Med, V3, P215, DOI 10.1089/acm.1997.3.215
[10]  
Courneya K.S., 1999, Psychology, Health Medicine, V4, P181, DOI DOI 10.1080/135485099106315